Diseases
Companies
Products
Mechanisms of Action
Sites
AKT
70 Products
556 Diseases
8860 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
10
20
30
40
50
60
70
80
90
100
Epidaza
(chidamide) / Chipscreen, Meiji Seika, Eisai, HUYA Bioscience
Kinenza
(enzastaurin) / Denovo, Aytu BioPharma
MK-2206
/ Merck (MSD)
ipatasertib
(GDC-0068) / Roche
perifosine
(D21266) / AEterna Zentaris
capivasertib
(AZD5363) / Otsuka, AstraZeneca
Estybon
(rigosertib) / Onconova, SymBio Pharma, Knight Therap
Turalio
(pexidartinib) / Daiichi Sankyo
ONC201
/ Chimerix
7-Hydroxystaurosporine
(UCN-01) / National Cancer Institute
afuresertib
(LAE002) / Laekna Therap
uprosertib
(LAE003) / Laekna Therap
ST266
/ Noveome Biotherap
Hocena
(antroquinonol) / Golden Biotechnology
Phenoxodiol
(idronoxil) / MEI
miransertib
(MK-7075) / Merck (MSD)
sonolisib
(PX 866) / Seagen
ABTL0812
/ Ability Pharma
atiprimod
(SK&F106615) / Synergy Pharmaceuticals Inc.
triciribine phosphate
(VQD 002) / VioQuest, Prescient Therap
LY2780301
/ Eli Lilly
alirinetide
(GM604) / Genervon
Archexin
(RX 0201) / Ocuphire Pharma, Zhejiang Haichang Bio-Tech
CMX-2043
/ Ischemix
DFN-529
/ Diffusion Pharma
GSK690693
/ GSK
IPL344
/ Immunity Pharma
PCUR-101
/ Pellficure
SY-007
/ Yabao Pharma
TAS-117
/ Otsuka
oleandrin
(PBI-05204) / Phoenix Biotech
quinacrine
(CBL0102) / Incuron
AT13148
/ Otsuka
BAY 1125976
/ Bayer
M2698
/ EMD Serono
ME-143
/ MEI
OB318
/ Microbio
SR13668
/ SRI International
TAS0612
/ Otsuka
XL418
/ Exelixis
vevorisertib
(ARQ 751) / Merck (MSD)
